Personal care products group Reckitt Benckiser (LON:RB.) said first-half pretax profit rose 9.5% to £1.11 billion as net revenue grew 23% on a reported basis to £3 billion.
Investment management group Brooks Macdonald (LON:BRK) reported record discretionary funds under management of £12.4 billion for the year ended 30 June 2018.
Shares in GlaxoSmithKline (LON:GSK) slipped as it revealed its application to market a new biologic drug for chronic obstructive pulmonary disease had been rejected by the FDA.
British American Tobacco (LON:BATS) said adjusted profit from operations fell 5.4% to £4.8 billion for the first half of the year.
Fashion retailer Joules (LON:JOUL) reported a 28.5% jump in full-year pre-tax profits to £13 million on revenue of £185.9 million, up 18.4%.
Niche plastics supplier Victrex (LON:VCT) said third quarter revenue rose 10% to £84 million, but warned of a tougher final three months ahead.
Telecoms heavyweight Vodafone (LON:VOD) reported a 4.9% fall in group total revenue to €10.9 billion, due to the adoption of IFRS 15 and currency headwinds.
Shares in compound semiconductor wafer manufacturer IQE (LON:IQE) jumped 5.2p to 106.6p as it reported double-digit sales growth on a constant currency basis.
Pharmaceuticals major AstraZeneca (LON:AZN) has agreed to offload the European commercial rights to Atacand and Atacand Plus, to Cheplapharm Arzneimittel.
Shares in precision instruments maker Spectris (LON:SXS) tumbled 143p to 2,457p (as at 10:50 BST) as it warned of slowing sales growth.
